Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE2
47 participants
INTERVENTIONAL
2006-05-31
2006-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Efficacy, Safety and Tolerability of a Novel Malathion Formulation in Patients 2 Years and Older With Head Lice
NCT00963508
Efficacy, Safety and Tolerability of a Novel Malathion Formulation in Patients 2 Years and Older With Head Lice
NCT00927472
A Study to Evaluate the Efficacy and Safety of a Leave-in Spray in Subjects With Head Lice Infestation
NCT05565820
Effectiveness of "No More" Anti-lice Medical Device to Kill Lice and Lice Eggs
NCT02569580
Efficacy and Safety of Summers Non-Pesticide Lice Asphyxiator (L.A.)for the Treatment of Head Lice
NCT00479310
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
This study was designed to compare use of Nice 'n Clear neem-based conditioning lotion when used with two different types of comb. One arm of the study was planned so that participants were combed using a plastic louse detection and removal comb (wet combing with conditioner method), in which it was expected the combing process would play a major role in efficacy. The other arm was planned so that participants were combed using a regular grooming comb, which would normally have little effect for removing head lice from the hair.
Comparison of the efficacy outcome in the two groups would determine whether the Nice 'n Clear neem-based conditioning lotion exhibited any effect to eliminate infestation independent of the combing
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Neem-based lotion plus louse comb
Neem-based conditioning lotion plus head louse detection and removal comb
Neem-based lotion plus louse comb
Neem-based conditioning lotion was applied to washed and towel dried hair followed by systematic combing using a head louse detection and removal comb
Neem-based lotion plus grooming comb
Neem-based conditioning lotion plus regular grooming comb
Neem-based lotion plus grooming comb
Neem-based conditioning lotion was applied to washed and towel dried hair followed by combing through using a regular grooming comb
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Neem-based lotion plus louse comb
Neem-based conditioning lotion was applied to washed and towel dried hair followed by systematic combing using a head louse detection and removal comb
Neem-based lotion plus grooming comb
Neem-based conditioning lotion was applied to washed and towel dried hair followed by combing through using a regular grooming comb
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* People who give written informed consent and/or, if the participant is below 16 years of age, whose guardian gives written informed consent to participate in the study. Assent/verbal assent forms will be required for those between the ages of 4 and 16 years of age. There is no maximum age limit.
* Participants must be available for the duration of the study i.e. 15 days.
Exclusion Criteria
* People who have undergone a course of antibiotic treatment using Cotrimoxazole, Trimethoprim or Septrin within the previous 4 weeks, or who are currently taking such a course.
* People whose hair has been bleached, colour treated, or semi-permanently waved within the previous 2 weeks, this includes the use of semi-permanent colouring agents. Home use wash in/wash out colouring agents are acceptable.
* People who have taken part in another clinical study within 4 weeks prior to entry to this one.
* Females who are pregnant or breast-feeding.
* Participants who have already taken part in this study.
* People who have a known allergy to any of the ingredients of Nice 'n Clear Lotion (including allergy to Paraben preservatives)
* Children under 6 months of age.
6 Months
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Leeds Health Protection Unit
UNKNOWN
PN Lee Statistics and Computing Ltd
UNKNOWN
Nelsons
OTHER
Medical Entomology Centre
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ian F Burgess
Director
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ian F Burgess
Role: PRINCIPAL_INVESTIGATOR
Medical Entomology Centre
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Medical Entomology Centre
Cambridge, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
Final Report Summary - ClearBrush (A Novel Integrated Ultrasonic Brush and Sonically Activated Lotion to Provide a Full System Approach to the Eradication of the European Head Louse Menace)
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CTNC01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.